2 employees
Cytune’s goal is to turn novel concepts into best-in class immunotherapeutics restoring and activating the immune system to fight cancer.
2007
Cytune Pharma SAS raised undisclosed on January 1, 2010
Investors: ABAB - Atlantique Business Angels Booster